BofA raised the firm’s price target on Elanco to $20 from $18 and keeps a Buy rating on the shares. With the core business driving a beat, “solid” Q2 guidance, and the 2024 product approval timing pushouts being shorter than expected by some, the firm calls the Q1 report “an encouraging update” from Elanco.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN: